Skip to content

Comparison of Usefulness of furosemide and budesonide Nebulizations for Attenuating Postoperative Sore Throat

Comparison of Usefulness of furosemide and budesonide Nebulizations for Attenuating Postoperative Sore Throat

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1800015215
Enrollment
Unknown
Registered
2018-03-15
Start date
2018-05-01
Completion date
Unknown
Last updated
2022-01-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative Sore Throat

Interventions

group F:aerosol inhalation of furosemide 40mg
group B:aerosol inhalation of budesonide 2mg

Sponsors

Plastic Surgery Hospital, The Chinese Academy of Medical Sciences, Peking Union Medical College
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 55 Years

Inclusion criteria

Inclusion criteria: American Society of Anesthesiologists (ASA) Class I-II, Aged 18-55 years, Normal body mass index range (18.5-23.9 kg / m2), Mallampatti grade 1-2, No respiratory/ circulatory complications, Normal pulmonary functionNormal hepatic and renal function, Patients will be selected for general anesthesia through the nasotracheal intubation undergoing cranial and maxillofacial surgery, Patients able to provide written informed consent and to fulfil study request.

Exclusion criteria

Exclusion criteria: Patients with history of respiratory tract infection within 2 weeks, Oral and ENT diseases and surgical history, Knot hoof tissue disease, Diabetes mellitus. Expected difficult airway and intubation, twice or more intubated patients, Preoperative and intraoperative use of anticholinergic drugs, non-steroidal anti-inflammatory drugs or hormone drugs, Change the patient's position and surgical approach temporarily in progress, Test drug allergy, Patients who cannot tolerate aerosol inhalation, With reading or communication disorders, Unsuitable for the study for every other reasons, in the opinion of the investigator.

Design outcomes

Primary

MeasureTime frame
postoperation throat pain;hoarseness of voice;foreign body sensation in oropharyngeal area;

Secondary

MeasureTime frame
xerostomi;nausea;Vomiting;Pain site of postoperative sore throat;cough;

Countries

China

Contacts

Public ContactAn Jie

Plastic Surgery Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College

ange0721@163.com+86 15801626150

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026